A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against pneumocystis pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect.
A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against pneumocystis pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect.
用于白血病及各种实体瘤,如非小细胞癌、结直肠癌、前列腺癌、膀胱癌、胃癌、乳腺癌、胰腺癌、宫颈癌等。
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2005/07/13 | Phase 1 | Completed | |||
2004/08/18 | Phase 2 | Completed | |||
2004/08/12 | Phase 2 | Completed | |||
2004/04/09 | Phase 2 | Completed | Grupo Oncologico Cooperativo del Sur | ||
2003/01/27 | Phase 2 | Completed | |||
2001/08/31 | Phase 1 | Completed | U.S. Bioscience | ||
2001/08/31 | Phase 1 | Completed | |||
2001/08/31 | Phase 3 | Completed | |||
2001/08/31 | Phase 3 | Completed | |||
2001/08/31 | Not Applicable | Completed | U.S. Bioscience |
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|
No NMPA products found for this drug
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug